Today in the Journal Nature it is reported that there is a panel of four genes that when expressed enable breast cancer cells to metastasize to the lungs. Those genes EREG, MMP1, MMP2 and Cox2 when shut off have dramatic effect. These results make us question the utility of pulling drug like Vioxx (a COX2 inhibitor) off the market. Perhaps we can find a way to give this drug to those who need it and will not have adverse drug reactions. I am betting Vioxx will see the light of day again.
What do you think?
Wednesday, April 11, 2007
Genes predict metastases
Posted by Steve Murphy MD at 6:33 PM
Labels: Breast cancer, celcoxib, celebrex, cetuximab, Colon cancer, Cox2, erbitux, EREG, ImClone, Lung cancer, metastases, MMP1, MMP2, prostate cancer, vioxx
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment